Helix BioPharma

(OTC) HBPCF

Current Price$1.71

Market Cap$130.61M

Since IPO (2010)-87%

5 Year-55%

1 Year+190%

1 Month-1%

Helix BioPharma Financials at a Glance

Market Cap

$130.61M

Revenue (TTM)

CA$0.00

Net Income (TTM)

-CA$3.37M

EPS (TTM)

-$0.03

P/E Ratio

-53.61

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.71

Volume

1,000

Open

$1.71

Price

$1.71

Volume

1,000

Open

$1.71

Previous Close

$1.71

Daily Range

$1.71 - $1.71

52-Week Range

$0.60 - $1.73

Estimated Earnings Date

Jun 17, 2026

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.71

Volume

1,000

Open

$1.71

Previous Close

$1.71

Daily Range

$1.71 - $1.71

52-Week Range

$0.60 - $1.73

Estimated Earnings Date

Jun 17, 2026

HBPCF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Helix BioPharma

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Thomas Mehrling, MD, PhD

Website

www.helixbiopharma.com

Headquarters

Toronto, ON M5H 2Y4, CA

HBPCF Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-49%

Return on Capital

-22%

Return on Assets

-16%

Earnings Yield

-1.87%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$130.61M

Shares Outstanding

76.38M

Volume

1.00K

Avg. Volume

21.094

Financials (TTM)

Gross Profit

-CA$7.22K

Operating Income

-CA$5.00M

EBITDA

-CA$5.00M

Operating Cash Flow

-CA$4.00M

Capital Expenditure

CA$0.00

Free Cash Flow

-CA$4.00M

Cash & ST Invst.

CA$64.64K

Total Debt

CA$333.15K

Helix BioPharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2026YOY CHG

Revenue

CA$0.00

N/A

Gross Profit

-CA$999.00

+54.0%

Gross Margin

0.00%

N/A

Market Cap

$130.61M

N/A

Market Cap/Employee

$18.66M

N/A

Employees

N/A

Net Income

-CA$670.78K

+56.6%

EBITDA

-CA$688.77K

+55.3%

Quarterly Fundamentals

Name

Q3 2026YOY CHG

Total Cash

CA$2.84M

+297.4%

Total Debt

CA$358.88K

N/A

Accounts Receivable

CA$27.99K

-90.2%

Inventory

CA$0.00

N/A

Long Term Debt

CA$0.00

N/A

Short Term Debt

CA$358.88K

N/A

Return on Assets

-15.54%

N/A

Return on Invested Capital

-22.47%

N/A

Free Cash Flow

-CA$879.71K

+36.3%

Operating Cash Flow

-CA$879.71K

+36.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

VICPVicapsys Life Sciences, Inc.

VICPVicapsys Life Sciences, Inc.$1.46+0.00%

INNMFAmplia Therapeutics Limited

INNMFAmplia Therapeutics Limited$0.08+0.00%

ACHFFArch Biopartners Inc.

ACHFFArch Biopartners Inc.$0.40+13.14%

OTLCOncotelic Therapeutics, Inc.

OTLCOncotelic Therapeutics, Inc.$0.05+3.90%

ZIVOZIVO Bioscience, Inc.

ZIVOZIVO Bioscience, Inc.$3.69+0.00%

RLFTFMindMaze Therapeutics Holding S.A.

RLFTFMindMaze Therapeutics Holding S.A.$0.27-18.68%

TCNAFTransCanna Holdings Inc.

TCNAFTransCanna Holdings Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.89-0.00%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$83.18+0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$36.66-0.07%

SMRNuScale Power

SMRNuScale Power$11.48+0.11%

FFord Motor Company

FFord Motor Company$14.09+0.01%

INTCIntel

INTCIntel$133.91+0.11%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$179.35-0.07%

Questions About HBPCF

What is the current price of Helix BioPharma?

Helix BioPharma is trading at $1.71 per share.

What is the 52-week range for Helix BioPharma?

Over the past 52 weeks, Helix BioPharma has traded between $0.60 and $1.73.

How much debt does Helix BioPharma have?

As of the most recent reporting period, Helix BioPharma reported total debt of CA$263.76K.

How much cash does Helix BioPharma have on hand?

Helix BioPharma reported CA$2.09M in cash and cash equivalents in its most recent financial results.

What is Helix BioPharma’s dividend yield?

Helix BioPharma does not currently have a dividend yield.

Helix BioPharma

Helix BioPharma Financials at a Glance

HBPCF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Helix BioPharma

HBPCF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Helix BioPharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About HBPCF

What is the current price of Helix BioPharma?

What is the 52-week range for Helix BioPharma?

How much debt does Helix BioPharma have?

How much cash does Helix BioPharma have on hand?

What is Helix BioPharma’s dividend yield?

Premium Investing Services